Intrinsic Value of S&P & Nasdaq Contact Us

Grifols, S.A. GRFS NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - General • ES • USD

SharesGrow Score
62/100
3/7 Pass
SharesGrow Intrinsic Value
$50.59
+495.2%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Grifols, S.A. (GRFS) trades at a trailing P/E of 15.2, forward P/E of 9.6. Trailing earnings yield is 6.56%, forward earnings yield 10.37%. PEG 0.10 (Peter Lynch undervalued ≤1.0). Graham Number is $12.06.

Criteria proven by this page:

  • VALUE (77/100, Pass) — P/E is below market average (15.2); PEG ≤ 1.0 — Peter Lynch undervalued (0.10); earnings yield beats bond yields (6.56%).
  • Forward P/E 9.6 (down from trailing 15.2) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.10 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 6.56% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 10.37% as earnings recover.

Overall SharesGrow Score: 62/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
62/100
SG Score
View full scorecard →
VALUE
77/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
40/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
56/100
→ Income
GROWTH
83/100
→ Income
~
INCOME
45/100
→ Income

Valuation Snapshot — GRFS

Valuation Multiples
P/E (TTM)15.2
Forward P/E9.6
PEG Ratio0.10
Forward PEG0.18
P/B Ratio1.16
P/S Ratio0.81
EV/EBITDA10.0
Per Share Data
EPS (TTM)$0.58
Forward EPS (Est.)$0.88
Book Value / Share$11.06
Revenue / Share$10.94
FCF / Share$1.14
Yields & Fair Value
Earnings Yield6.56%
Forward Earnings Yield10.37%
Dividend Yield1.68%
Graham Number$12.06
SharesGrow IV$50.59 (+495.2%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 19.1 7.45 2.80 2.57 2.07%
2017 20.1 0.95 3.67 3.09 1.64%
2018 18.4 -1.78 2.59 2.44 2.54%
2019 21.9 2.38 2.53 2.69 1.74%
2020 16.7 -0.72 2.02 1.94 1.09%
2021 35.7 -0.57 1.22 1.36 3.75%
2022 29.2 1.97 0.96 0.89 0.01%
2023 168.0 -2.37 1.32 1.08 -
2024 31.1 0.20 0.83 0.68 0.02%
2025 14.0 0.09 1.03 0.75 2.27%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.80 $4.05B $545.46M 13.5%
2017 $0.97 $4.32B $662.7M 15.3%
2018 $0.87 $4.49B $596.64M 13.3%
2019 $0.91 $5.1B $625.15M 12.3%
2020 $0.90 $5.34B $618.55M 11.6%
2021 $0.39 $4.93B $265.33M 5.4%
2022 $0.31 $6.06B $208.28M 3.4%
2023 $0.09 $6.59B $59.32M 0.9%
2024 $0.23 $7.21B $156.92M 2.2%
2025 $0.57 $7.23B $386.13M 5.3%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.88 $0.81 – $0.94 $7.84B $7.68B – $8B 1
2027 $1.14 $1.11 – $1.17 $8.37B $8.21B – $8.55B 1
2028 $1.39 $1.36 – $1.43 $8.89B $8.71B – $9.07B 1
2029 $1.60 $1.56 – $1.64 $9.51B $9.33B – $9.71B 1
2030 $1.77 $1.72 – $1.82 $9.67B $9.48B – $9.87B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message